Kenneth M Kernen

Disclosure information not submitted.

Presentation(s):

• Exploring Clinical Evidence of a Treatment Option for Metastatic Castration-Sensitive Prostate Cancer | Sponsored by: Astellas Pharma and Pfizer Oncology

  Saturday, April 29, 2023
  12:00 PM – 1:00 PM CST

• MP51-15: Temporarily Implanted Nitinol Device versus Prostatic Urethral Lift for Minimally Invasive Surgical Treatment of Benign Prostatic Hyperplasia with Lower Urinary Tract Symptoms: A Matching-Adjusted Indirect Comparison

  Sunday, April 30, 2023
  7:00 AM – 9:00 AM CST

• Case-based Learnings on a Treatment Approach for Certain Patients With High-Risk NMIBC | Sponsored by: Merck & Co., Inc.

  Sunday, April 30, 2023
  12:30 PM – 1:30 PM CST